New Fairfield, CT, United States of America

Donald Diehl

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Endo Pharmaceuticals Inc., Penwest Pharmaceuticals Company. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Diehl. Retrieved from https://idiyas.com/inventor/donald-diehl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Donald Diehl

Introduction

Donald Diehl is a notable inventor based in New Fairfield, CT, who has made significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Diehl has focused on developing advanced formulations that enhance patient care and treatment options.

Latest Patents

Among his latest patents, Diehl has developed sustained release formulations of nalbuphine and its pharmaceutically acceptable salts. These patents include methods for creating these formulations and their applications in treating patients suffering from pain. His work aims to improve the efficacy and comfort of pain management therapies.

Career Highlights

Diehl has had a distinguished career, working with prominent companies such as Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Company. His experience in these organizations has allowed him to refine his skills and contribute to innovative pharmaceutical solutions.

Collaborations

Throughout his career, Diehl has collaborated with talented professionals, including Anand R. Baichwal and Philip A. Goliber. These partnerships have fostered a creative environment that has led to the development of impactful pharmaceutical innovations.

Conclusion

Donald Diehl's work in the pharmaceutical industry exemplifies the importance of innovation in improving patient care. His sustained release formulations of nalbuphine represent a significant advancement in pain management, showcasing his dedication to enhancing therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…